Controlling Cellular Machinery - Diagnostics and Therapeutics

The summary for the Controlling Cellular Machinery - Diagnostics and Therapeutics grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the DARPA Defense Sciences Office, which is the U.S. government agency offering this grant.
Controlling Cellular Machinery - Diagnostics and Therapeutics: DARPA is soliciting research proposals for the development of synthetic regulatory genetic elements that can be used in mammalian cells. The proposed research should comprise approaches that enable fundamental advances to the development and broad application of synthetic regulatory elements for in vivo biomedical applications to detect, treat, or prevent disease. Technical challenges that need to be addressed include, but are not limited to, discovery, characterization, evolution or design, and demonstration of orthogonal and modular genetic regulatory elements; construct stability and function in the cell; and synthesis, amplification, and delivery of novel circuits in mammalian cells. The designed modules must limit specific interactions with the cellular metabolism or milieu to the desired performance characteristics and demonstrate maintenance of independent function without interference long enough to achieve the intended clinical effect. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice. Proposers that intend to pursue nucleic acid vaccines as an application are referred to the companion announcement, Controlling Cellular Machinery - Vaccines, DARPA-BAA-11-22.
Federal Grant Title: Controlling Cellular Machinery - Diagnostics and Therapeutics
Federal Agency Name: DARPA Defense Sciences Office
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: DARPA-BAA-11-23
Type of Funding: Cooperative Agreement Procurement Contract
CFDA Numbers: 12.910
CFDA Descriptions: Research and Technology Development
Current Application Deadline: Mar 03, 2011
Original Application Deadline: Mar 03, 2011
Posted Date: Nov 29, 2010
Creation Date: Nov 29, 2010
Archive Date: May 03, 2011
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
Dr. Daniel Wattendorf

BAA Coordinator [[email protected]]
Similar Government Grants
Structures Uniquely Resolved to Guarantee Endurance (SURGE)
GOLDen hour extended EVACuation (GOLDEVAC)
Material Synthesis Technologies for Universal and Diverse Integration Opportunities (M-STU...
Scientific Feasibility (SciFy)
Expeditionary Carbon Utilization for energy Resilience and Stabilization (ExCURSion)
Wide Band Gap Semiconductors for RF Applications (WBGS-RF)
Robust Integrated Power Electronics (RIPE)
Microantenna Arrays:Technology and Applications (MIATA)
More Grants from the DARPA Defense Sciences Office
Structures Uniquely Resolved to Guarantee Endurance (SURGE)
Young Faculty Award (YFA) 2024
Defense Sciences Office (DSO) Office-wide BAA
Synthetic Quantum Nanostructures (SynQuaNon)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com